Middle East & Africa Genotyping Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Genotyping Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Genotyping Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Genotyping Market Regional Analysis

6.2 Middle East & Africa Genotyping Market Revenue 2021-2031 (US$ Million)

6.3 Middle East & Africa Genotyping Market Forecast Analysis

7. Middle East & Africa Genotyping Market Analysis – by Product Type

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Reagents and Kits

7.2.1 Overview
7.2.2 Reagents and Kits: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Bioinformatics

7.3.1 Overview
7.3.2 Bioinformatics: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Genotyping Services

7.4.1 Overview
7.4.2 Genotyping Services: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Genotyping Market Analysis – by Technology

8.1 Microarray

8.1.1 Overview
8.1.2 Microarray: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Capillary Electrophoresis

8.2.1 Overview
8.2.2 Capillary Electrophoresis: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Sequencing

8.3.1 Overview
8.3.2 Sequencing: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Polymerase Chain Reaction

8.4.1 Overview
8.4.2 Polymerase Chain Reaction: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Matrix-Assisted Laser Desorption / MALDI-TOF

8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Technologies

8.6.1 Overview
8.6.2 Other Technologies: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Genotyping Market Analysis – by Application

9.1 Pharmacogenomics

9.1.1 Overview
9.1.2 Pharmacogenomics: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Diagnostics and Personalized Medicine

9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Animal Genetics

9.3.1 Overview
9.3.2 Animal Genetics: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.4 Agricultural Biotechnology

9.4.1 Overview
9.4.2 Agricultural Biotechnology: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.5 Other Applications

9.5.1 Overview
9.5.2 Other Applications: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Genotyping Market Analysis – by End user

10.1 Pharmaceutical and Biopharmaceutical Companies

10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Diagnostic and Research Laboratories

10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Academic Institutes

10.3.1 Overview
10.3.2 Academic Institutes: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Other End Users

10.4.1 Overview
10.4.2 Other End Users: Middle East & Africa Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Middle East & Africa Genotyping Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East & Africa Genotyping Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Middle East & Africa Genotyping Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East & Africa Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 South Africa: Middle East & Africa Genotyping Market Breakdown, by Product Type
11.2.1.1.2 South Africa: Middle East & Africa Genotyping Market Breakdown, by Technology
11.2.1.1.3 South Africa: Middle East & Africa Genotyping Market Breakdown, by Application
11.2.1.1.4 South Africa: Middle East & Africa Genotyping Market Breakdown, by End user

11.2.1.2 Saudi Arabia: Middle East & Africa Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East & Africa Genotyping Market Breakdown, by Product Type
11.2.1.2.2 Saudi Arabia: Middle East & Africa Genotyping Market Breakdown, by Technology
11.2.1.2.3 Saudi Arabia: Middle East & Africa Genotyping Market Breakdown, by Application
11.2.1.2.4 Saudi Arabia: Middle East & Africa Genotyping Market Breakdown, by End user

11.2.1.3 UAE: Middle East & Africa Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 UAE: Middle East & Africa Genotyping Market Breakdown, by Product Type
11.2.1.3.2 UAE: Middle East & Africa Genotyping Market Breakdown, by Technology
11.2.1.3.3 UAE: Middle East & Africa Genotyping Market Breakdown, by Application
11.2.1.3.4 UAE: Middle East & Africa Genotyping Market Breakdown, by End user

11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Genotyping Market Breakdown, by Product Type
11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Genotyping Market Breakdown, by Technology
11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Genotyping Market Breakdown, by Application
11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Genotyping Market Breakdown, by End user

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Hoffmann-La Roche Ltd.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 QIAGEN NV.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Merck KGaA.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Thermo Fisher Scientific Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 BioTek Instruments, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Illumina Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Danaher Corp.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Bio-Rad Laboratories Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 GE HealthCare Technologies Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Standard BioTools Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Laboratory Corp of America Holdings.

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Beckman Coulter Inc.

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 BGI.

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 Takara Bio Inc.

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

14.15 DiaSorin SpA.

14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East & Africa Genotyping Market